The reduction of L was even more pronounced when breast tumor characteristics were added instead of age, but the accuracies were not improved, except for the blood biomarker panels correlating with CD3 and CD8 infiltration in the invasive front (Table 3). This evidence concerns the gene CD8A and breast neoplasm.